130495-83-9

Upstream product

• 69832-48-0 ((3aR,5S,6R,6aR)-tetrahydro-2,2-dimethyl-5-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)furo[2,3-d][1,3]dioxol-6-yl)methanol 
• 98-88-4 benzoyl chloride 
• 130469-40-8 3-deoxy-3-<(benzoyloxy)methyl>-1,2:5,6-di-O-isopropylidene-α-D-allofuranose 

Downstream Products

• 130469-42-0 5-O-benzoyl-2-deoxy-2-<(benzoyloxy)methyl>-3-O-formyl-D-ribofuranose 
• 69827-90-3 5-O-benzoyl-3-C-benzoyloxymethyl-3-deoxy-1,2-O-isopropylidene-α-D-ribo-pentofuranose 
• 129399-11-7 N²-isobutyryl-9-<(2S,4R,5R)-4-<(benzoyloxy)methyl>-5-2-(acetylthio)ethyl)tetrahydrofuran-2-yl>guanine 
• 129426-44-4 N²-isobutyryl-9-<(2R,4R,5R)-4-<(benzoyloxy)methyl>-5-2-(acetylthio)ethyl)tetrahydrofuran-2-yl>guanine 
• 129399-18-4 N²-isobutyryl-7-<(2α,4R,5R)-4-<(benzoyloxy)methyl>-5-2-(hydroxyethyl)tetrahydrofuran-2-yl>guanine 
• 129399-15-1 N²-isobutyryl-7-<(2β,4R,5R)-4-<(benzoyloxy)methyl>-5-2-(hydroxyethyl)tetrahydrofuran-2-yl>guanine 
• 129399-14-0 1-<(2R,4R,5R)-4-<(benzoyloxy)methyl>-5-(2-hydroxyethyl)tetrahydrofuran-2-yl>uracil 
• 134056-18-1 1-<(2R,3R,4R,5R)-3-<<3-(trifluoromethyl)benzoyl>oxy>-4-<(benzoyloxy)methyl>-5-(2-hydroxyethyl)tetrahydrofuran-2-yl>uracil 
• 129954-15-0 N²-isobutyryl-7-<(2R,4R,5R)-4-<(benzoyloxy)methyl>-5-<2-(acetylthio)ethyl>tetrahydrofuran-2-yl>guanine 
• 129399-10-6 N²-isobutyryl-9-<(2RS,4R,5R)-4-<(benzoyloxy)methyl>-5-2-(hydroxyethyl)tetrahydrofuran-2-yl>guanine 
• 134056-17-0 (1R,5R,6R,7R)-6-<(benzoyloxy)methyl>-7-<<3-(trifluoromethyl)benzoyl>oxy>-2,8-dioxabicyclo<3.2.1>octane 
• 134056-14-7 3,5-dideoxy-3-<(benzoyloxy)methyl>-1,2-O-isopropylidene-α-D-allofuranose 
• 134056-13-6 3,5,6-trideoxy-5,6-didehydro-3-<(benzoyloxy)-methyl>-1,2-O-isopropylidene-α-D-allofuranose 
• 441044-21-9 Benzoic acid (2R,3S,4R)-4-hydroxy-2-(2-hydroxy-ethyl)-5-methoxy-tetrahydro-furan-3-ylmethyl ester 

Relevant academic research and scientific papers

Building Blocks for Oligonucleotide Analogues with Dimethylene Sulfide, Sulfoxide, and Sulfone Groups Replacing Phosphodiester Linkages

Two routes are presented for the synthesis of 3',5'-bishomodeoxyribonucleosides, building blocks needed to synthesize oligodeoxynucleotide analogues where the OPO2O groups are replaced by CH2SCH2, CH2SOCH2, and CH2SO2CH2 units.Two of these have been coupl

A Ring-Enlarged Oxetanocin A Analogue as an Inhibitor of HIV Infectivity

Two ring-expanded analogues (compounds 2 and 3) of the anti-HIV fermentation product oxetanocin A (1) were synthesized from commercially available diacetone D-glucose.Antiviral testing against HIV in ATH8 cells revealed that the ring-expanded analogue 2 p